483 Roundup: FDA Hits Facilities for Inadequate CAPAs, Investigations
The FDA flagged three U.S. facilities and two in Europe for a variety of deficiencies including CAPA failures and investigations of nonconforming products.
Source: The GMP Letter
The FDA flagged three U.S. facilities and two in Europe for a variety of deficiencies including CAPA failures and investigations of nonconforming products.
Source: The GMP Letter